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ABSTRACT   
Photodynamic Therapy offers multiple advantages to treat nonmelanoma skin cancer compared to conventional 
treatment techniques such as surgery, radiotherapy or chemotherapy. Among these advantages are particularly relevant 
its noninvasive nature, the use of non ionizing radiation and its high selectivity. However the therapeutic efficiency of 
the current clinical protocol is not complete in all the patients and depends on the type of pathology. Emerging strategies 
to overcome its current shortcomings include the use of nanostructures that can act as carriers for conventional 
photosensitizers and improve the treatment selectivity and provide a controlled release of the photoactive agent. In this 
work, a model for photodynamic therapy combined with gold nanocarriers for a photosensitizer commonly used in 
dermatology is presented and applied to a basal cell carcinoma in order to predict the cytotoxic agent spatial and 
temporal evolution.     
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1. INTRODUCTION  
Photodynamic Therapy (PDT) is an optical treatment modality used in several clinical fields to destroy malignant 
tissues1. It consists of the administration of a photosensitive substance known as photosensitizer which is activated by the 
subsequent optical irradiation of the tumor area. Thus it is based on a photochemical interaction between three essential 
components: the photosensitizer, the light and the oxygen. As a consequence reactive oxygen species are produced and 
destroy the cancerous cells. On the other hand the photosensitizer fluorescence allows to use it as contrast agent for 
fluorescence based imaging, providing PDT with diagnostic functionality used in several applications such as guided 
resection, treatment planning and monitoring, outcome treatment assessment or the study of the interactions produced 
during PDT and the mechanisms involved in cell death2. 
In dermatology, PDT offers multiple advantages to treat nonmelanoma skin cancer compared to conventional treatment 
techniques such as surgery, radiotherapy or chemotherapy3. Among these advantages are particularly relevant its 
noninvasive nature, the use of non ionizing radiation and its high selectivity. However the therapeutic efficiency of the 
current clinical protocol is not complete in all the patients and depends on the type of pathology. 
Emerging strategies to overcome the current PDT shortcomings related to the photosensitizer accumulation in the target 
tissue or the optical radiation distribution include the use of nanostructures with conventional PDT. The future potential 
ability of nanotechnology to enhance the critical issues of PDT and finally improve its therapeutic effectiveness makes 
essential to assess dosimetric approaches based on the combined use of PDT and nanoparticles. These last ones can act 
as carriers for conventional photosensitizers, as excitation energy transducers or active photodynamic elements4, 5. 
Among the former, gold nanoparticles have demonstrated to be excellent carriers for the photosensitizer delivery6. As 
well as being particularly interesting due to their ease of synthesis and chemical modification or their unique optical 
properties7. The use of nanoparticles as delivery vehicle has a great interest to provide an enhanced treatment selectivity 
in the target tissue and a controlled release of the photoactive agent. The nanoparticles encapsulating the photosensitizer 
molecules or with the phtosensitizer covalently attached to the nanoparticles surface, make possible to deliver high 
payloads of photoactive agent, including hydrophobic agents as well as an improved therapeutic selectivity and 
accumulation in the tumor tissues owing to the enhanced permeability retention (EPR) effects and antibody conjugation. 
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The future development of customized dosimetry for novel nanoparticle-based PDT requires predictive models able to 
adjust a great amount of parameters of different nature in order to get an optimal tumor removal8. These models must 
consider the photosensitizer-nanoparticle distribution in the malignant tissue, its influence in the optical radiation 
distribution and the photochemical reactions underlying PDT in order to get an accurate dosimetric adjustment. Previous 
studies have theoretically investigated the spatial distribution of nanoparticles by particle trajectory tracking models or 
its optical and thermal properties, however there is a very limited number of works related to the development of 
mathematical models that characterize the whole photodynamic process with nanoparticles, which includes not only the 
photosensitizer-nanoparticle distribution in the malignant tissue but also its influence in the optical radiation distribution 
and the photochemical reactions evolution. This work is devoted to a predictive model focused on the use of gold 
nanoparticles as carriers for a photosensitizer commonly used in dermatology. Section 2 describes the model basis and 
thereafter it is applied to a basal cell carcinoma. The obtained results are presented in Section 3. Finally, the conclusions 
are listed in the Section 4.  
 
2. PREDICTIVE MODEL FOR PHOTODYNAMIC THERAPY COMBINED WITH GOLD 
NANOPARTICLES  
The predictive model for nanoparticle-based PDT takes into account the main processes involved in the photodynamic 
process as well as those effects produced by the administration of gold nanoparticles in the photosensitizer distribution 
and the optical propagation. 
The nanoparticles transport mechanism in the tumor tissue once they leave the bloodstream through the leaky tumor 
vasculature is obtained by means of a diffusion model considering the vessel walls as the main barrier to the diffusion 
into the target tissue. The time dependent distribution of the nanoparticles in the tumor tissue is described by Fick's first 
law of mass flow in equation (1), which is widely employed to model the transport of solutes in tissues. According to this 
law the diffusion of nanoparticles occurs from areas of high concentration, the vessel walls in this case, to those where 
the concentration is lower. In this expression j
r
 is the flux vector,  TN  is the concentration of nanoparticles and D   is 
the diffusivity. 
 Tj D gradN= − ⋅
r
 (1) 
The temporal evolution of the nanoparticles concentration depending on distance from the vessel wall, x , can be 
calculated as9: 
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where oN   is the initial nanoparticles concentration bound to the vessel wall at the beginning of the diffusion time t=0, 
K  is the vessel wall permeability and τ  is the particle relaxation time. The photosensitizer concentration at the end of 
the incubation period is calculated from the nanoparticles distribution profile in the malignant tissue and the 
photosensitizer payload carried by the nanoparticle. 
 
The optical radiation distribution in the tissue is obtained by means of the Monte Carlo method applied to the Radiation 
Transport Equation (RTE)10, 11, in the expression (3) for a steady-state situation, taking into account the effects of the 
nanopaticles on the absorption and scattering via Mie Theory12.  The model assumes that the scattering events are 
sufficiently numerous as to the light to be considered incoherent, in such a way that polarization or interference effects 
can be neglected. As a consequence, the basic parameter of light is the specific intensity, ˆ( , )I r s . The radiation is 
expected to be at the point rr , and to follow the direction ŝ . The scattering events are treated according to the scattering 
phase function, ˆ ˆ( ')p s s⋅ , which contains the probabilities of light to be scattered in the different directions. Optical 
radiation comes from direction ˆ 's  and is redirected to ŝ . According to the differential RTE, the radiation from a particle 
attenuates due to absorption and scattering and also gains power because another particle can scatter light in the direction 
of the particle of interest1. Thus in (3), the absorption and scattering events are taken into account by means of aμ  and 
Proc. of OSA-SPIE Vol. 8803  88030N-2
sμ  respectively. Both of them include the optical properties of the nanoparticles and the type of pathological tissue 
where they are embedded. 
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The Monte Carlo method has demonstrated its applicability and accuracy, to solve the radiation transport equation 
compared with exact solutions. In this work the implementation of the Monte Carlo method applied to the RTT model is 
the one by Wang and Jacques10. The Monte Carlo program assumes that the optical beam is infinitely narrow, and that it 
has perpendicular incidence. The second assumption is reasonable, but the former can provoke serious disappointments 
with the reality, particularly if the dimensions of the optical spot and the tissue are of the same order. In order to correct 
this limitation, another program by the same authors11 implements the convolution of the results. In this way, the solution 
of the Monte Carlo analysis can be later transformed for taking into account a cylindrical geometry of the laser beam like 
the one used in this work. This implementation of the Monte Carlo model is also multi-layered, so it is possible to define 
several layers of different materials, with their borders always perpendicular to the laser beam, which is very useful in 
the skin tissues due to they usually can be divided in different strata.  
Mie’s theory permits to calculate the efficiency factors of scattering, Qsca, and extinction, Qext, for homogeneous 
spherical nanoparticles with radius r  taking into account the complex refractive index of the material m by means of the 
expressions (4) and (5) respectively. Then the efficiency factor of absorption Qabs can be easily calculated from these last 
ones as in expression (6). 
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The amplitude coefficients for the scattered field, na  and nb , are calculated as in the expressions (7) and (8), involving 
spherical Bessel functions13. In these expressions, x kr=  is the size parameter, 2 /k π λ=  is the wave number, λ  is 
the wavelength in the ambient medium and 1μ  is the ratio of the magnetic permeability of the sphere to the magnetic 
permeability of the ambient medium. 
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The efficiency factors previously obtained permit to know the nanoparticles absorption, a NPμ , and scattering, s NPμ , 
coefficients taking into account the cross section of the spherical nanoparticles and the number of nanoparticles per unit 
volume as:  
 2aNP abs Tr Q Nμ π=  (9) 
 2sNP sca Tr Q Nμ π=  (10) 
Once the photosensitizer accumulation and light distribution are know, the interaction of both elements with the ground 
state oxygen via a reactions known as Type II triggers a photochemical reaction responsible for singlet oxygen 
production14. This kind of reactive oxygen is considered as the cytotoxic element in charge of killing the carcinogenic 
cells. Finally the photochemical reactions that take place during PDT can be modeled by means of a differential 
Proc. of OSA-SPIE Vol. 8803  88030N-3
equations system15, 16, (11) to (16). This photochemical model is based in the Jablonski diagram for the generation of 
singlet oxygen in a type II reaction and takes into account the electronic transitions of the molecular components 
involved in the photodynamic procedure such as the photosensitizer or the oxygen. Its solutions permit to analyze the 
temporal evolution of the main molecular components concentrations such as the photosensitizer in ground state, 0S , in 
singlet excited state, 1S  and in triplet excited state T , the oxygen in ground state, 
3
2O , singlet oxygen 
1
2O  and the 
intracellular singlet oxygen receptors, R . In these equations, 1τ  is the relaxation time from state 1S  to 0S , 3τ  is the 
relaxation time from state T  to 0S , 0τ is the relaxation time from state 
1
2O  to 
3
2O , 10η  is the quantum yield of the 
transition from state 1S  to 0S , 13η  is the quantum yield of the transition from 1S  to T , 30η  is the quantum yield of T  
transition to 0S , 0η  is the quantum yield of 
1
2O  transition to 
3
2O , sα  is the efficiency factor for energy transfer from 
T  to 3 2O , kpb  stands for the biomolecular photobleaching rate, kcx  is the biomolecular cytotoxicity rate, ksc  is the 
rate of reaction of 1 2O  with various oxygen scavengers, ν  is light speed in tissue, ρ  is the photon density present at a 
point, psaσ  is the absorption cross-section of 0S  molecules, P  is the rate of oxygen diffusion and perfusion and U is 
the cell damage repair rate. The stiff differential equations system was solved by means of a differential equation solver 
(ode15s) within the Matlab® platform. It was necessary to adjust relative and absolute error tolerances in order to obtain 
coherent results.  
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3. RESULTS 
The structure of the tissue sample employed corresponds to a basal cell carcinoma of 1 mm in depth crossed by a blood 
vessel whereby the particles are diffused in the tumor located at 0.5 mm from the tumor surface. The diffusion model 
previously presented allowed us to obtain the time dependent accumulation of nanoparticles bearing the photosensitizer 
in the tumor tissue once they leave the bloodstream through the leaky tumor vasculature taking into account a vessel 
permeability of 2.82·10-7 cm/s and a diffusion coefficient  of  6.13·10-7 cm2/s, 9,17. The initial concentration of 
nanoparticles in the vessel wall was fixed to 2·1019 cm-3 and the diffusion time was 3 h. The photoactive agent 
concentration at the end of the incubation period was calculated from the nanoparticles distribution profile in the 
malignant tissue assuming a payload of 32 molecules of photosensitizer per nanoparticle. 
The optical absorption and scattering properties of 80 nm gold nanospheres were obtained at the laser wavelength used in 
PDT (630-635 nm) with the photosensitizer Methyl Aminolevulinate-Protoporphyrin IX (MAL-PpIX). The optical 
distribution in the multilayer tissue sample was obtained taking into account the tissue optical properties18, 19  summarized 
in Table 1 and those of the nanoparticles for a cylindrical optical beam perpendicular to the tissue sample and an 
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irradiance of 100 mW/cm2. In this case the tumor tissue layer corresponds to a basal cell carcinoma. Figure 1 shows the 
efficiency factors of scattering, extinction and absorption obtained by means of Mie’s theory for the gold nanoparticles 
employed.   
Table 1.  Tissue sample optical properties at 635 nm (µa: absorption coefficient, µs: scattering coefficient, g: anisotropy of 
scattering, n: refractive index) 
Tissue layer µa (cm-1) µs (cm-1) g 
Tumor 1.5 104.76 0.79 
Vessel wall 6 414 0.91 




Figure 1. Efficiency factors of scattering (Qsca), extinction (Qext) and absorption (Qabs) for gold nanoparticles. 
 
Literature related to well known photosensitizers of the porphyrins family was explored to assign the parameters values 
related to the photosensitizer PpIX when they were not available20. Thus the absorption cross-section of the PpIX 
molecule at 635 nm was derived from a study21  of the cellular photosensitizing properties of PpIX carried out in a 
transformed murine keratinocyte cell line and set to 0.37·10-15 cm2. The relaxation time from singlet excited state to 
ground state was set to 7.4 ns as reported earlier from fluorescence measurements in cells incubated with 5-
aminolevulinic acid induced PpIX22. The triplet state lifetime in vivo23 in skin was set to 26 µs and the relaxation time of 
singlet oxygen23 to its ground state to 0.04 µs. Quantum yield transitions between different energetic states were adopted 
to be similar to those previously considered for the photosensitizer Photofrin® η10 = 0.2, η 30 = 0.3, η0 = 0.3 and η 13 = 
0.8 as well as biomolecular photobleaching, citotoxicity and scavenging rates that were set to 2·10-10 cm3s-1, 2·10-9 cm3s-1 
and 1·10-9 cm3s-1, respectively16. The initial concentration of S1, T and singlet oxygen is 0 cm-3 due to this kind of 
molecules are not present in the tissue when the optical irradiation period starts. The tissue sample was supposed to be 
homogeneously oxygenated and without oxygen supply limitations. The initial concentration of cellular oxygen was set 
to 5·1017 cm-3, and diffusion and perfusion rates16 to 1·1012 cm-3s-1. The initial concentration of intracellular molecular 
singlet oxygen receptors was 5·1017cm-3, the scavenger concentration was 1·103 cm-3 and the cell damage repair rate16 
2.6·1012 cm-3s-1. 
The photochemical model was employed to obtain the evolution of the different molecular components involved in the 
photochemical reactions during the treatment progression. Figure 2 shows the singlet oxygen concentration produced in 
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the tumor tissue as a function of the distance to the tumor surface and to the center of the optical beam as the therapy 
progresses. Attending to the results, it can be clearly observed a preferential accumulation of singlet oxygen in those 
zones closer to the nanoparticles supplier vessel. Therefore the therapy effects related to the cytotoxic action of this 
reactive oxygen would be more pronounced in the tumor areas closer to the nanoparticles supply (i.e. the vessel for 
systemic administration) and those types of nonmelanoma skin cancers highly vascularized would be more susceptible to 
suffer singlet oxygen mediated destruction.  
Regarding to the temporal singlet oxygen production, Figure 2 presents the singlet oxygen concentration (cm-3) as a 
function of the distance to the tumor surface, z, and the distance to the center of the cylindrical optical beam, r, during 

























































































Figure 2. Singlet oxygen concentration (cm-3) as a function of cylindrical coordinates (z: distance to the tumor surface and r 
is the distance to the center of the cylindrical optical beam perpendicular to the tissue sample) at a) 1·10-24 s,  b) 6 s, c) 300 s 
and d) 600 s during the therapy. 
As it can be observed in Fig. 2 a), singlet oxygen has not yet been produced just when the irradiation starts. However 
shortly after (Fig. 2 b)) it reaches a high concentration preferentially in those areas near the vessel walls that will 
progressively decay faster in those points far from the center of the optical beam. Those tumor areas where the 
production of singlet oxygen is not enough to destroy the malignant tissue will persist after the therapy. Therefore the 
results showed could help in a future to choose the proper treatment parameters with the purpose of maximize the 
cytotoxic agent production and consequently the malignant tissue removal. However these results must be interpreted 
carefully due to the great amount of parameters of different nature involved in the photodynamic process and the large 
variability between biological media. 
4. CONCLUSIONS 
Despite of the multiple advantages of PDT to treat nonmelanoma skin cancer such as its noninvasive nature, the use of 
non ionizing radiation or its high selectivity, the therapeutic efficiency of the current clinical protocol is not complete in 
all the patients and depends on the type of pathology. Emerging strategies to overcome the current PDT shortcomings 
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include the use of nanotechnology combined with conventional PDT. The future potential ability of nanotechnology to 
enhance the critical issues of PDT and improve its therapeutic effectiveness makes essential to assess dosimetric 
approaches based on the combined use of PDT and nanoparticles. These last ones can assume different roles in the 
photodynamic process as carriers for conventional photosensitizers, excitation energy transducers or active 
photodynamic elements. Gold nanoparticles have unique optical properties, are easy to synthesize and have demonstrated 
to be excellent carriers for the photosensitizer delivery.  
Together with the development of customized dosimetry for novel nanoparticle-based therapeutic strategies, the use of 
predictive models is essential to optimize the adjustment of the great amount of parameters involved in the final 
treatment result. A first approach to model the temporal photodynamic response of a basal cell carcinoma using gold 
nanoparticles as delivery vehicle for a photosensitizer commonly used in dermatology was presented. The distribution of 
the injected nanocarriers from the vessel wall was characterized by means of Fick´s law which permits to know the 
spatial photosensitizer accumulation from the vascular supply. The efficiency factors of absorption, scattering and 
extinction were calculated by means of Mie’s theory for homogeneous spherical nanoparticles and the complex 
refractive index of gold. The propagation of light in the tumor tissue with gold nanoparticles embedded was obtained by 
a numerical Monte Carlo method. Finally a photochemical model provided the temporal evolution of the molecular 
components involved in the photodynamic process.  
The results provide the temporal and spatial evolution of the cytotoxic agent produced during the photochemical 
reactions when the photosensitizer is delivered bound to gold nanoparticles injected in the bloodstream. The citotoxic 
agent produced is crucial to predict the photodynamic treatment response with nanoparticles due to its direct relation 
with the tumor necrosis. It was observed a preferential accumulation of singlet oxygen in those zones closer to the 
nanoparticles supplier vessel. Therefore the therapy effects related to the cytotoxic action of this reactive oxygen could 
be expected to be more pronounced in the tumor areas closer to the nanoparticles supply which indicates that those types 
of nonmelanoma skin cancers highly vascularized would be more susceptible to suffer singlet oxygen mediated 
destruction for a systemic administration of nanoparticles. Future works will consider a more complex tumor vasculature 
which matches closely with the specific characteristics of the target tumor. 
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